Edition:
United States

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

4.10USD
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
$4.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,829
52-wk High
$6.45
52-wk Low
$2.33

Latest Key Developments (Source: Significant Developments)

Atyr Pharma receives U.S. FDA orphan drug designation for the treatment of limb girdle muscular dystrophy with Resolaris
Tuesday, 28 Feb 2017 08:00am EST 

Atyr Pharma Inc :Atyr Pharma Receives U.S. FDA orphan drug designation for the treatment of limb girdle muscular dystrophy with Resolaris™.  Full Article

Atyr Pharma enters into $20 million credit facility
Monday, 21 Nov 2016 08:00am EST 

Atyr Pharma Inc : Intends to use additional capital to pay off existing indebtedness . Entered into a $20 million credit facility with Silicon Valley Bank and Solar Capital Ltd . Atyr Pharma will receive $10 million after execution of loan agreement . Atyr Pharma Inc - under terms, two additional $5 million tranches will be available to Atyr Pharma, subject to achievement of certain specified milestones .Atyr Pharma enters into $20 million credit facility.  Full Article

Atyr Pharma Inc qtrly loss per share $0.65
Wednesday, 10 Aug 2016 04:05pm EDT 

Atyr Pharma Inc : Atyr Pharma announces second quarter 2016 operating results . Atyr Pharma Inc qtrly loss per share $0.65 .Currently expect that our cash, cash equivalents and investments will be sufficient to fund our anticipated operations into 2018..  Full Article

Atyr Pharma qtrly loss per share $0.68
Wednesday, 11 May 2016 04:25pm EDT 

Atyr Pharma Inc : Qtrly loss per share $0.68 .Atyr pharma announces first quarter 2016 operating results.  Full Article

BRIEF-Atyr Pharma Says On Dec 22, Co Entered Into Amendment To Loan And Security Agreement Dated As Of Nov 18, 2016

* ATYR PHARMA SAYS ON DEC 22, CO ENTERED INTO AMENDMENT TO LOAN AND SECURITY AGREEMENT DATED AS OF NOV 18, 2016 - SEC FILING